Merlin Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Merlin Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,215	Closed	-$172K	–	86
2021 Q4	$172K	Buy	+11,215	New	+$148K	0.2%	71

Other funds holding NPTN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Merlin Capital's NPTN Position: Q1 2022 in Review

Merlin Capital sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 11,215 shares — an estimated $172K sold.

Merlin Capital first reported a position in NPTN in Q4 2021 and held it in 1 quarter. The position peaked at $172K in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

Merlin Capital reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
Merlin Capital sold 11,215 NEOPHOTONICS CORP shares in Q1 2022, an estimated $172K.
Merlin Capital first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 1 quarter.
Merlin Capital's NEOPHOTONICS CORP position peaked at $172K in Q4 2021.
143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on Merlin Capital's 13F filing for Q1 2022, filed 16 May 2022.